Brief: Scancell Holdings Says iSCIB1+ Cohort Is Now Expected To Start In Q1 2024

Scancell Holdings

28/11/2023 07:48

Nov 28 (Reuters) - Scancell Holdings PLC  SCLP.L :
    * SCANCELL HLDS  - UPDATE ON SCOPE TRIAL
    * SCANCELL HOLDINGS PLC - 11 OUT OF 13 PATIENTS HAVE
RESPONDED
INCREASING ORR TO 85%
    * SCANCELL HOLDINGS PLC - ONE PATIENT HAS ACHIEVED COMPLETE
RESPONSE FOLLOWING TREATMENT
    * SCANCELL HOLDINGS PLC - ISCIB1+ COHORT IS NOW EXPECTED TO
START
IN Q1 2024

Source text for Eikon:  ID:nRSb8275Ua 
Further company coverage:  SCLP.L 

 ((Reuters.Briefs@thomsonreuters.com;))